Detalles de la búsqueda
1.
Real-World Evidence Shows Clinicians Appropriately Use the Prognostic 40-Gene Expression Profile (40-GEP) Test for High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
Cancer Invest
; 40(10): 911-922, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36073945
2.
Enhanced metastatic risk assessment in cutaneous squamous cell carcinoma with the 40-gene expression profile test.
Future Oncol
; 18(7): 833-847, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34821148
3.
Integrating the 40-Gene Expression Profile (40-GEP) Test Improves Metastatic Risk-Stratification Within Clinically Relevant Subgroups of High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) Patients.
Dermatol Ther (Heidelb)
; 14(3): 593-612, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38424384
4.
Clinical Utility of the 40-Gene Expression Profile (40-GEP) Test for Improved Patient Management Decisions and Disease-Related Outcomes when Combined with Current Clinicopathological Risk Factors for Cutaneous Squamous Cell Carcinoma (cSCC): Case Series.
Dermatol Ther (Heidelb)
; 12(2): 591-597, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34951694
5.
Current Methods and Caveats to Risk Factor Assessment in Cutaneous Squamous Cell Carcinoma (cSCC): A Narrative Review.
Dermatol Ther (Heidelb)
; 12(2): 267-284, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34994967
6.
Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients.
Diagn Pathol
; 17(1): 32, 2022 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35216597
7.
Impact of a prognostic 40-gene expression profiling test on clinical management decisions for high-risk cutaneous squamous cell carcinoma.
Curr Med Res Opin
; 36(8): 1295-1300, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32372702
8.
Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
Clin Cancer Res
; 21(21): 4831-44, 2015 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26124202
9.
Wee-1 kinase inhibition overcomes cisplatin resistance associated with high-risk TP53 mutations in head and neck cancer through mitotic arrest followed by senescence.
Mol Cancer Ther
; 14(2): 608-19, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25504633
10.
The p53-reactivating small molecule RITA induces senescence in head and neck cancer cells.
PLoS One
; 9(8): e104821, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25119136
11.
Chk1/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53.
Mol Cancer Ther
; 12(9): 1860-73, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23839309
12.
TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.
Clin Cancer Res
; 18(1): 290-300, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22090360
Resultados
1 -
12
de 12
1
Próxima >
>>